Non-small cell lung cancer: Emerging molecular targeted and immunotherapeutic agents
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Genetics,Oncology
Reference302 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J. Clin.,2018
2. Treatment- and immune-related adverse events of immune checkpoint inhibitors in advanced lung cancer;Shao;Biosci. Rep.,2020
3. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015
4. Lung cancer: biology and treatment options;Lemjabbar-Alaoui;Biochim. Biophys. Acta,2015
5. Efficacy and safety of tyrosine kinase inhibitors in advanced non-small-cell lung cancer harboring epidermal growth factor receptor mutation: a network meta-analysis;Alanazi;Lung Cancer Manag.,2020
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The interaction between m6A modification and noncoding RNA in tumor microenvironment on cancer progression;International Immunopharmacology;2024-10
2. Alkaloids of Aconiti Lateralis Radix Praeparata inhibit growth of non-small cell lung cancer by regulating PI3K/Akt-mTOR signaling and glycolysis;Communications Biology;2024-09-11
3. Integrated machine learning survival framework to decipher diverse cell death patterns for predicting prognosis in lung adenocarcinoma;Genes & Immunity;2024-08-31
4. SIRT1 silencing ameliorates malignancy of non-small cell lung cancer via activating FOXO1;Scientific Reports;2024-08-28
5. Advances in Non-Small Cell Lung Cancer: Current Insights and Future Directions;Journal of Clinical Medicine;2024-07-18
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3